论文部分内容阅读
目的观察鼠神经生长因子(m NGF)穴位注射治疗儿童痉挛型脑瘫的临床效果。方法 110例痉挛型脑瘫患儿,采取数字随机法分成观察组和对照组,各55例。对照组采取常规康复训练,观察组在对照组基础上采取鼠神经生长因子穴位注射治疗。比较两组临床效果。结果治疗后两组血乳酸水平均低于治疗前,差异有统计学意义(P<0.05);且观察组患儿治疗后血乳酸水平低于对照组(P<0.05)。治疗后两组粗大运动功能测试量表(GMFM)总评分高于治疗前(P<0.05);且观察组治疗后GMFM总评分高于对照组(P<0.05)。两组患儿不良反应发生率比较,差异无统计学意义(P>0.05)。结论鼠神经生长因子穴位注射治疗儿童痉挛型脑瘫的临床效果显著,并且较为安全,是痉挛型脑瘫的一线治疗方法。
Objective To observe the clinical effect of m NGF injection on children with spastic cerebral palsy. Methods One hundred and ten children with spastic cerebral palsy were randomly divided into observation group and control group with 55 cases each. Control group to take routine rehabilitation training, the observation group in the control group on the basis of the mouse nerve growth factor acupuncture treatment. The clinical effects of two groups were compared. Results After treatment, the level of blood lactate in both groups was lower than that before treatment (P <0.05). The level of blood lactate in the observation group was lower than that in the control group (P <0.05). After treatment, the GMFM scores of the two groups were higher than those before treatment (P <0.05), and the GMFM scores of the observation group were higher than those of the control group (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion The clinical effect of acupoint injection of rat nerve growth factor in children with spastic cerebral palsy is significant and safe, which is the first-line treatment for spastic cerebral palsy.